期刊文献+

艾司西酞普兰联合认知行为治疗对抑郁焦虑共病患者的疗效 被引量:10

Effects of escitalopram combined with cognitive therapy in treatment of depression and anxiety
下载PDF
导出
摘要 目的:评价艾司西酞普兰联合认知行为治疗对抑郁焦虑共病患者的治疗效果。方法:将符合ICD-10诊断标准的62例抑郁焦虑共病患者随机分为研究组和对照组各31例,研究组给予艾司西酞普兰合并认知行为治疗,对照组单予艾司西酞普兰治疗。疗程8周。应用临床疗效标准及汉密尔顿抑郁量表(HAMD)、汉密尔顿焦虑量表(HAMA)定期评定疗效,不良反应量表(TESS)评定安全性。结果:在治疗第1、2、4、8周末,研究组疗效优于对照组,具有显著性统计学意义(P<0.01)。结论:艾司西酞普兰联合认知行为治疗对抑郁焦虑共病患者效果优于单用艾司西酞普兰。 Objective : To determine the efficacy of escitalopram combined with cognitive behavior therapy for treating the depression and anxiety. Methods : Sixty - two patients with depression and anxiety who met ICD - 10 criteria of depression and anxiety were randomly divided into the treatment group ( treated with escitalopram in addition to cognitive behavior therapy ) and the control group ( only with escitalopram). All the patients in the two groups received the treatment for 8 weeks. The therapeutic effects were assessed by Hamilton Depression Rating Scale ( HAMD ) , HAMA and treatment emergent symptom scale ( TESS ). Results : At the 1 st, 2nd,4tb and 8th weekend, the effects in the treatmnt group were better than those in the control group, respectively ( P 〈 0.01 ). Conclusions:Escitalopram combined with cognitive behavior therapy is more satisfactoy than escitalopram in depression and anxiety.
出处 《天津药学》 2013年第4期42-44,共3页 Tianjin Pharmacy
关键词 艾司西酞普兰 认知行为治疗 抑郁焦虑 escitalopram cognitive behavior therapy epression and anxiety
  • 相关文献

参考文献11

  • 1Fava M,Rush A J,Alpert J E,et al. What clinical and symptom featuresand co morbid disorders characterize outpatients with anxious major de- pressive disorder: a replication and extension [ J]. Can J Psychiatry, 2006,51:823.
  • 2Connor K M, Pavidsm J R T. The neurobiology of generalized anxiety disorder[ J]. Buil psychiatry, 1998, 44:1284.
  • 3Burke W J. Escitalopram [ J ]. Expert Opin Investig Drugs, 2002, 11 (10) :1477.
  • 4Goodman W K, Bose A, Wang Q. Treatment of generalized anxiety disor- der with escitalopram : Pooled results from doubleblind, placebo - con- trolled trials [ J ]. J Affect D isord,2005,87 ( 2 - 3 ) : 161.
  • 5Kasper S, Stein D J, Loft H,et al. Escitalopram in the treatment of social anxiety disorder: randomised, placebo - controlled, flexible - dosage study[ J]. Br J Psychiatry,2005,18 ( 3 ) : 222.
  • 6李妍,沈一峰,李静,许秀峰,高成阁,李华芳.艾司西酞普兰治疗伴随焦虑症状抑郁症的随机对照临床研究[J].中国新药与临床杂志,2010,29(12):919-922. 被引量:8
  • 7汤臻,吴天诚,李鸣.艾司西酞普兰与舍曲林治疗伴焦虑症状抑郁症患者疗效比较[J].临床精神医学杂志,2012,22(6):419-420. 被引量:14
  • 8王春雨,蔡年强,王鹏飞.艾司西酞普兰治疗抑郁焦虑共病的对照研究[J].四川精神卫生,2012,25(1):43-44. 被引量:3
  • 9伍海姗,常麦会,李乐华,赵靖平,欧建君,张宏耕,谢世平,陈斌,陈艳卿,赵振环,高成阁,杜波.艾司西酞普兰治疗抑郁症伴焦虑的疗效分析[J].国际精神病学杂志,2012,39(2):69-73. 被引量:15
  • 10Davidson J R, Bose A, Wang Q. Safety and efficacy ofescitalopram in the long - term treatment of generalized anxiety disorder[ J ]. J Clin Psy- chiatry ,2005, 66( 11 ) : 1441.

二级参考文献37

  • 1陈登榜,刘延友,杨波,李葳,郑航,王正荣.海马β_1和β_2肾上腺素受体与抑郁症的关系[J].四川生理科学杂志,2006,28(2):50-51. 被引量:9
  • 2张亚同,傅得兴.艾司西酞普兰的药理及临床评价[J].中国新药杂志,2006,15(22):1979-1983. 被引量:46
  • 3钱敏才,沈鑫华,林敏.艾司西酞普兰与舍曲林治疗门诊抑郁症的对照研究[J].上海精神医学,2007,19(2):95-97. 被引量:51
  • 4沈渔邨.精神病学[M].北京:人民卫生出版社,2009.251.
  • 5ZIMMERMAN M, CHEI,MINSKI I, MCDERMUT W. Major depression disorder and axis I diagnostic comorbidity [J]. J Clin Psvchiatry 2002, 63(3): 187-193.
  • 6MURDOCH D, KEAM SJ. Escitalopram: a review of its use in the management of major depressive disorder[J]. Drugs, 2005, 65 (16) : 2379-2404.
  • 7GORMAN JM, KOROTZER A, SU G. Efficacy comparison of escitalopram and citalopram in the treatment of major depressive disorder: pooled analysis of placebo-controlled trials [J]. CNS Spectr, 2002, 7(4 Suppl 1 ): 40-44.
  • 8PAPAKOSTAS GI, LARSEN K. Testing anxious depression as a predictor and moderator of symptom improvement in major depressive disorder during treatment with escitalopram [J]. Eur Arch Psychiatry Clin Neurosci, 2010(in press).
  • 9OWENS M J, KNIGNT DL, NEMEROFF CB. Second generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine[J]. Biol Psychiatry, 2001, 50(5): 345-350.
  • 10COLONNA L, ANDERSEN HF, REINES EH. A randomized, double-blind, 24-week study of eseitalopram(10 mg/day)versus eitalopram (20 mg/day)in primary care patients with major depressive disorder[J]. Curr Med Res Opin, 2005, 21 (10): 1659-1668.

共引文献33

同被引文献64

引证文献10

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部